DNA-RNA Polymerase: A Potential Drug Target and Biomarker for Cancer

Target Name: DNA-Directed RNA Polymerase

NCBI ID: P10265

DNA-Directed RNA Polymerase

Other Name(s): None

DNA-RNA Polymerase: A Potential Drug Target and Biomarker for Cancer

DNA-Directed RNA Polymerase (DNA-RNA polymerase), also known as nonspecified subtype, is a critical enzyme in the process of DNA replication and transcription. It is an enzyme that uses a small fragment of DNA as a template to synthesize a new RNA molecule. DNA-RNA polymerase is found in all living cells and is responsible for the production of RNA from the DNA template.

One of the unique features of DNA-RNA polymerase is its ability to synthesize RNA in multiple copies, which is essential for the process of gene expression. DNA-RNA polymerase is also able to recognize specific sequences of DNA and faithfully synthesize specific RNA molecule. This specificity is crucial for the regulation of gene expression and is a key feature that makes DNA-RNA polymerase a potential drug target.

Another potential drug target for DNA-RNA polymerase is its role in cancer.DNA-RNA polymerase is involved in the regulation of the cell cycle and has been shown to be involved in the development and progression of many types of cancer. For example, studies have shown that high levels of DNA-RNA polymerase are associated with the development of breast cancer. Additionally, DNA-RNA polymerase has also been shown to be involved in the regulation of cell division and has been linked to the development of leukemia.

DNA-RNA polymerase is also a potential biomarker for certain types of cancer. The expression of DNA-RNA polymerase has been shown to be elevated in a variety of cancer types, including breast cancer, lung cancer, and colorectal cancer. Additionally, some studies have shown that the level of DNA-RNA polymerase is also associated with the severity of certain types of cancer, such as breast cancer.

In addition to its potential as a drug target and biomarker, DNA-RNA polymerase is also an important enzyme in the process of DNA replication and transcription. It is essential for the production of RNA from the DNA template, which is necessary for the regulation of gene expression and the development and progression of many types of cancer.

In conclusion, DNA-RNA polymerase is a complex enzyme that is involved in the regulation of gene expression and the process of DNA replication and transcription. Its specificity and role in the regulation of the cell cycle make it a potential drug target and biomarker for a variety of cancer types. Further research is needed to fully understand the mechanisms of DNA-RNA polymerase and its potential as a drug.

Protein Name: DNA-Directed RNA Polymerase (nonspecified Subtype)

The "DNA-Directed RNA Polymerase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNA-Directed RNA Polymerase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets